Hypertrophic cardiomyopathy (HCM) was first described in the late 1950s as a disease typified by substantial thickening of the myocardium, particularly the left ventricular wall, with no overt cause.
Genetic analysis of palmoplantar keratoderma highlights diagnostic value and associated risks, like cardiomyopathy.